We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Using Protein Biomarkers Increases the Chances of Success in Clinical Trials
Industry Insight

Many clinical trials fail due to lack of efficacy. But while some of this may be due to poor target selection during the drug discovery process, it’s becoming increasingly clear that only certain patients respond to treatments. So how exactly does precision medicine increase the likelihood of success in clinical trials?

Read More

Simplifying Next-generation Sequencing in the Clinic
Industry Insight

We recently spoke to Luca Quagliata, Ph.D., Global Head of Medical Affairs for Clinical NGS and Oncology at Thermo Fisher Scientific, to discuss some of the barriers preventing full adoption of NGS-based genomic testing in hospitals, and learn more about a solution that can help to address these.

Read More

Behind the Scenes of MRI-based Liver Disease Diagnostics
Industry Insight

Early diagnosis of liver disease can be life-saving, particularly because the liver has an amazing capacity to regenerate – so it is possible to curb highly prevalent diseases such as fatty liver disease by making lifestyle changes. By taking advantage of magnetic resonance imaging (MRI), Perspectum Diagnostics are developing ways to improve diagnosis in the clinic and accelerate drug discovery.

Read More

Tackling Immune Dysregulation – A Key Driver of Disease
Industry Insight

Immune dysregulation plays a central role in many pathologies. We spoke with Dr Fabienne Charrier-Savournin, from Cisbio, to learn more about the mechanisms underpinning immune dysregulation and how this knowledge is applied for therapeutic intervention.

Read More

Detecting Sepsis Early
Industry Insight

We recently spoke to Elena Sukhacheva, Director Medical and Scientific Affairs at Beckman Coulter, to learn about some of the challenges of diagnosing sepsis early, and how measuring Monocyte Distribution Width can be used as a sepsis biomarker to aid the process.

Read More

Mass Spectrometry in the Clinical Lab: The Importance of Choosing a Medical Device
Industry Insight

In this interview, SCIEX’s Francis Fung highlights the benefits that mass spectrometry can bring to clinical laboratories, and discusses why when selecting a mass spectrometer, it is important to consider choosing a medical device.

Read More

Thermo Fisher Scientific Joins the Pistoia Alliance
Industry Insight

Recently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.

Read More

Celebrations All Round for Analysis Veterans
Industry Insight

As a stalwart in the biological and chemical analysis fields, JEOL celebrates its 70th anniversary this year. But that’s not all it is celebrating, with the appointment of 35-year veteran of JEOL USA, Bob Pohorenec as President of the company this year.

Read More

Infection Identification: Metagenomic Next-generation Sequencing vs PCR
Industry Insight

We recently spoke with Meredith Carpenter, Director of Assay Research and Development for Arc Bio, to learn more about the capabilities of metagenomic next-generation sequencing in identifying infections.

Read More

How a Female Executive Became a Leader in the Business of Science
Industry Insight

Trisha Rice, VP & GM Materials Science Business at Thermo Fisher Scientific, shares her experiences as a woman in science, and provides tips on how to be your most "authentic self" in the field.

Read More

 
Advertisement